+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lipid Microbubble Ultrasound Contrast Agent Market - Global Forecast 2026-2032- Product Image
Lipid Microbubble Ultrasound Contrast Agent Market - Global Forecast 2026-2032- Product Image
Sale

Lipid Microbubble Ultrasound Contrast Agent Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6152052
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Lipid Microbubble Ultrasound Contrast Agent Market is projected to reach USD 264.04 Million in 2026. It is expected to continue growing at a CAGR of 6.76%, reaching USD 389.78 Million by 2032.

Lipid Microbubble Ultrasound Contrast Agents: Executive Overview

Lipid microbubble ultrasound contrast agents enhance ultrasound imaging by improving blood-pool, vascular, and perfusion visualization. Their clinical relevance is linked to applications such as echocardiography, liver imaging, vascular assessment, and contrast-enhanced ultrasound-guided procedures. Adoption is shaped by diagnostic demand, regulatory requirements, reimbursement conditions, imaging infrastructure, clinician training, and the availability of compatible ultrasound systems.

Clinical Integration Is Reshaping Contrast-Enhanced Ultrasound

The landscape is shifting from highly specialized use toward broader integration of contrast-enhanced ultrasound into diagnostic pathways. Improvements in transducer performance, workflow software, examination protocols, and point-of-care imaging are supporting more consistent use. At the same time, healthcare providers are emphasizing safety, repeatability, reduced dependence on ionizing radiation, and efficient diagnosis. Barriers include operator variability, uneven training, procurement constraints, and differences in clinical guidelines across jurisdictions.

Artificial Intelligence Is Strengthening Interpretation and Workflow

Artificial intelligence is contributing to the analysis of contrast-enhanced ultrasound through automated lesion detection, motion compensation, segmentation, perfusion quantification, image-quality assessment, and decision support. These tools can help reduce interpretation variability and make dynamic enhancement patterns easier to evaluate. However, reliable deployment depends on representative training data, clinical validation, cybersecurity, explainability, interoperability, and regulatory oversight. AI is therefore an enabler of adoption rather than a substitute for expert clinical judgment.

Regional Dynamics Reflect Uneven Infrastructure and Regulation

North America benefits from established ultrasound infrastructure, specialist expertise, and active clinical research, while reimbursement and evidence requirements influence broader routine use. Europe combines strong academic and hospital networks with varied national procurement and reimbursement systems. Asia-Pacific presents diverse conditions, ranging from advanced imaging centers in Japan, Australia, and South Korea to rapidly expanding healthcare capacity in China and India. Latin America is influenced by urban concentration of specialist services, import dependence, and public-sector budget constraints. The Middle East is supported by investment in tertiary and private healthcare, although adoption varies by country. Africa shows selective use in referral hospitals and maternal, emergency, and resource-constrained care settings, with affordability, maintenance, training, and supply continuity remaining central considerations.

Major Economic and Institutional Groups Show Different Adoption Priorities

ASEAN markets are shaped by expanding diagnostic capacity, cross-border differences in regulation, and uneven specialist availability. BRICS countries combine large and diverse patient populations with varied public procurement systems, domestic manufacturing capabilities, and clinical infrastructure. The European Union emphasizes evidence, device compliance, data governance, and cross-border standards, while national reimbursement decisions remain important. G7 economies generally have mature imaging ecosystems and focus on clinical utility, workflow integration, and cost-conscious service delivery. GCC countries are supported by concentrated investment in advanced healthcare facilities but may rely on imported technologies and specialist recruitment. NATO members span mature and emerging health systems, with resilience, interoperability, and diagnostic readiness relevant to both civilian and defense medical settings.

Country Contexts Define Clinical Access and Implementation Conditions

Australia and Canada combine broad public healthcare responsibilities with geographically dispersed services, making portable imaging, training, and equitable access important. Brazil and Mexico face regional disparities and procurement complexity alongside substantial demand for diagnostic services. China and India are expanding imaging capacity, with differing provincial or state-level implementation conditions and strong interest in scalable workflows. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom have established clinical ecosystems in which guideline alignment, reimbursement, evidence generation, and hospital workflow determine utilization. Russia’s context is influenced by healthcare modernization priorities, regulatory conditions, and supply-chain resilience. In the United States, adoption is shaped by specialist practice patterns, reimbursement, clinical evidence, hospital purchasing, and integration with advanced ultrasound platforms.

Prioritize Evidence, Workflow Integration, and Equitable Deployment

Industry leaders should build adoption around clearly defined clinical use cases, robust safety documentation, and evidence that demonstrates diagnostic or workflow value. Partnerships with hospitals and professional societies can support protocol standardization, clinician education, and post-deployment monitoring. Products should emphasize compatibility with installed ultrasound systems, simple preparation and administration, dependable supply, and tools that assist-not obscure-clinical interpretation. Leaders should also prepare jurisdiction-specific regulatory and reimbursement strategies, strengthen data governance for AI-enabled features, and design service models suited to rural, mobile, and resource-constrained settings.

Methodology: Evidence-Based Synthesis of Clinical and Market-Relevant Drivers

This executive summary uses a structured qualitative synthesis focused on lipid microbubble ultrasound contrast agents. The assessment considers clinical applications, technology development, regulatory and reimbursement conditions, healthcare infrastructure, workflow requirements, regional and country-level differences, and the implications of artificial intelligence. Insights are framed without market estimates, forecasts, market shares, or company-specific claims. Geographic comparisons reflect broad system characteristics and should be validated against current local guidelines, procurement rules, and regulatory decisions before operational use.

The Opportunity Depends on Demonstrable Clinical Utility and Practical Access

Lipid microbubble ultrasound contrast agents are positioned within a diagnostic environment seeking safer, more flexible, and increasingly quantitative imaging. Sustained adoption will depend on credible clinical evidence, reliable administration and imaging workflows, trained users, compatible equipment, and appropriate reimbursement. Artificial intelligence can reinforce these factors by improving consistency and efficiency, but successful implementation requires validation and governance. The strongest strategies will connect product performance with measurable clinical needs while addressing regional differences in infrastructure, regulation, affordability, and specialist capacity.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Lipid Microbubble Ultrasound Contrast Agent Market, by Product Type
7.1. Introduction
7.2. Non Targeted
7.3. Targeted
7.3.1. Clinical Development Stage
7.3.1.1. Growth Factor Targeted
7.3.1.2. Integrin Targeted
7.3.2. Preclinical Development Stage
7.3.2.1. Antibody Targeted
7.3.2.2. Peptide Targeted
8. Lipid Microbubble Ultrasound Contrast Agent Market, by Distribution Channel
8.1. Introduction
8.2. Direct Sales
8.3. Indirect Sales
8.3.1. Distributors
8.3.2. Online Sales
8.3.2.1. Company Websites
8.3.2.2. Ecommerce Platforms
9. Lipid Microbubble Ultrasound Contrast Agent Market, by Application
9.1. Introduction
9.2. Cardiovascular Imaging
9.2.1. Echocardiography
9.2.2. Peripheral Vascular Imaging
9.3. Oncology
9.3.1. Breast Tumor Detection
9.3.2. Liver Tumor Detection
9.3.3. Prostate Tumor Detection
9.4. Radiology
9.4.1. Hepatic Imaging
9.4.2. Pancreatic Imaging
9.4.3. Renal Imaging
10. Lipid Microbubble Ultrasound Contrast Agent Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Diagnostic Imaging Centers
10.5. Hospitals
11. Lipid Microbubble Ultrasound Contrast Agent Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Lipid Microbubble Ultrasound Contrast Agent Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Lipid Microbubble Ultrasound Contrast Agent Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Bracco Imaging S.p.A.
15.2. Daiichi Sankyo Company, Limited
15.3. Fujifilm Toyama Chemical Co., Ltd.
15.4. General Electric Company
15.5. Lantheus Holdings, Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Lipid Microbubble Ultrasound Contrast Agent Market, Years Considered for the Study
FIGURE 2. Global Lipid Microbubble Ultrasound Contrast Agent Market, Research Design
FIGURE 3. Global Lipid Microbubble Ultrasound Contrast Agent Market, Research Framework
FIGURE 4. Global Lipid Microbubble Ultrasound Contrast Agent Market, Data Triangulation
FIGURE 5. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 9. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Lipid Microbubble Ultrasound Contrast Agent Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Lipid Microbubble Ultrasound Contrast Agent Market Segmentation & Coverage
TABLE 2. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, 2017-2032 (USD Million)
TABLE 3. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Non Targeted Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Non Targeted Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Non Targeted Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Targeted Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Targeted Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Targeted Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Clinical Development Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Clinical Development Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Clinical Development Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Growth Factor Targeted Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Growth Factor Targeted Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Growth Factor Targeted Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Integrin Targeted Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Integrin Targeted Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Integrin Targeted Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Preclinical Development Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Preclinical Development Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Preclinical Development Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Antibody Targeted Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Antibody Targeted Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Antibody Targeted Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Peptide Targeted Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Peptide Targeted Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Peptide Targeted Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 29. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Indirect Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Indirect Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Indirect Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Online Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Online Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Online Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Company Websites Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Company Websites Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Company Websites Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Ecommerce Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Ecommerce Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Ecommerce Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 48. Global Cardiovascular Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Cardiovascular Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Cardiovascular Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Echocardiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Echocardiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Echocardiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Peripheral Vascular Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Peripheral Vascular Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Peripheral Vascular Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Breast Tumor Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Breast Tumor Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Breast Tumor Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Liver Tumor Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Liver Tumor Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Liver Tumor Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Prostate Tumor Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Prostate Tumor Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Prostate Tumor Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Radiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Radiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Radiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Hepatic Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Hepatic Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Hepatic Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Pancreatic Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Pancreatic Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Pancreatic Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Renal Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Renal Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Renal Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 111. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 112. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 113. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 115. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 116. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 118. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 119. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 120. North America Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 123. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 124. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 125. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 126. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 128. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 129. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 131. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 132. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 133. Latin America Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 137. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 138. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 139. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 141. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 142. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 144. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 145. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 146. Europe Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 150. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 151. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 152. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 154. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 155. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 157. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 158. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 159. Middle East Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 163. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 164. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 165. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 167. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 168. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 170. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 171. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 172. Africa Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 177. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 178. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 179. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 181. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 182. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 184. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 185. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 186. ASEAN Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 189. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 190. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 191. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 192. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 194. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 195. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 197. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 198. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 199. GCC Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 203. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 204. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 205. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 207. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 208. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 210. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 211. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 212. European Union Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 215. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 216. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 217. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 218. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 220. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 221. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 223. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 224. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 225. BRICS Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 227. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 228. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 229. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 230. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 231. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 233. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 234. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 236. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 237. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 238. G7 Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 240. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 241. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 242. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 243. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 244. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 245. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 246. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 247. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 249. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 250. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 251. NATO Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Global Lipid Microbubble Ultrasound Contrast Agent Market Size, by Country, 2017-2032 (USD Million)
TABLE 253. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, 2017-2032 (USD Million)
TABLE 254. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 255. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 256. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 257. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 258. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 259. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 260. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 261. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 263. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 264. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 265. United States Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, 2017-2032 (USD Million)
TABLE 267. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 268. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 269. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 270. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 271. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 272. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 273. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 274. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 276. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 277. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 278. Canada Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, 2017-2032 (USD Million)
TABLE 280. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 281. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 282. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 283. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 284. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 285. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 286. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 287. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 288. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 289. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 290. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, by Radiology, 2017-2032 (USD Million)
TABLE 291. Mexico Lipid Microbubble Ultrasound Contrast Agent Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. Brazil Lipid Microbubble Ultrasound Contrast Agent Market Size, 2017-2032 (USD Million)
TABLE 293. Brazil Lipid Microbubble Ultrasound Contrast Agent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 294. Brazil Lipid Microbubble Ultrasound Contrast Agent Market Size, by Targeted, 2017-2032 (USD Million)
TABLE 295. Brazil Lipid Microbubble Ultrasound Contrast Agent Market Size, by Clinical Development Stage, 2017-2032 (USD Million)
TABLE 296. Brazil Lipid Microbubble Ultrasound Contrast Agent Market Size, by Preclinical Development Stage, 2017-2032 (USD Million)
TABLE 297. Brazil Lipid Microbubble Ultrasound Contrast Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 298. Brazil Lipid Microbubble Ultrasound Contrast Agent Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 299. Brazil Lipid Microbubble Ultrasound Contrast Agent Market Size, by Online Sales, 2017-2032 (USD Million)
TABLE 300. Brazil Lipid Microbubble Ultrasound Contrast Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 301. Brazil Lipid Microbubble Ultrasound Contrast Agent Market Size, by Cardiovascular Imaging, 2017-2032

Companies Mentioned

  • Bracco Imaging S.p.A.
  • Daiichi Sankyo Company, Limited
  • Fujifilm Toyama Chemical Co., Ltd.
  • General Electric Company
  • Lantheus Holdings, Inc.

Related Topics

Related Reports

Perfluorocarbon-based Ultrasound Contrast Agents Market - Global Forecast 2026-2032 - Product Image

Perfluorocarbon-based Ultrasound Contrast Agents Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Ultrasonic Microbubble Contrast Agents Market - Global Forecast 2026-2032 - Product Image

Ultrasonic Microbubble Contrast Agents Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Peripheral Vascular Imaging Contrast Media Market Size, Share & Trends Analysis Report by Modality (CT/ X-ray, Ultrasound), Product (Iodinated Contrast Media, Microbubble), End-use and Region with Growth Forecasts, 2025-2033 - Product Image

Peripheral Vascular Imaging Contrast Media Market Size, Share & Trends Analysis Report by Modality (CT/ X-ray, Ultrasound), Product (Iodinated Contrast Media, Microbubble), End-use and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
2025 Global Forecast for Ultrasound Contrast Agents Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Ultrasound Contrast Agents Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Contrast Enhanced Ultrasound Market Report 2026 - Product Image

Contrast Enhanced Ultrasound Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.